デフォルト表紙
市場調査レポート
商品コード
1330892

血液診断の世界市場

Hematology Diagnostics

出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 174 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.72円
血液診断の世界市場
出版日: 2023年08月17日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 174 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

血液診断の世界市場は2030年までに119億米ドルに達する

COVID-19後のビジネス環境が変化する中、2022年に76億米ドルと推計された血液診断の世界市場規模は、2030年には119億米ドルに達すると予測され、2022年から2030年にかけてCAGR 5.7%で成長すると予測されます。本レポートで分析されているセグメントの一つである消耗品は、CAGR 5.3%を記録し、分析期間終了時には78億米ドルに達すると予測されています。現在進行中のパンデミック後の回復を考慮し、機器セグメントの成長は今後8年間のCAGRを6.6%に修正しました。

米国市場は21億米ドル、中国はCAGR9.2%で成長すると予測

米国の血液診断市場は、2022年には21億米ドルになると推定されます。世界第2位の経済大国である中国は、2022年から2030年までの分析期間においてCAGR 9.2%で推移し、2030年までに27億米ドルの市場規模に達すると予測されています。その他の注目すべき地理的市場としては、日本とカナダがあり、2022年から2030年にかけてそれぞれ3%と4.8%の成長が予測されています。欧州では、ドイツがCAGR約3.9%で成長すると予測されています。

調査対象企業の例

  • Abbott Laboratories
  • Beckman Coulter, Inc.
  • F. Hoffmann-La Roche AG
  • Mindray Medical International Ltd.
  • Siemens Healthineers
  • Sysmex Corporation

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP16457

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Hematology Diagnostics Market to Reach $11.9 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Hematology Diagnostics estimated at US$7.6 Billion in the year 2022, is projected to reach a revised size of US$11.9 Billion by 2030, growing at aCAGR of 5.7% over the period 2022-2030. Consumables, one of the segments analyzed in the report, is projected to record 5.3% CAGR and reach US$7.8 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Instruments segment is readjusted to a revised 6.6% CAGR for the next 8-year period.

The U.S. Market is Estimated at $2.1 Billion, While China is Forecast to Grow at 9.2% CAGR

The Hematology Diagnostics market in the U.S. is estimated at US$2.1 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.7 Billion by the year 2030 trailing a CAGR of 9.2% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3% and 4.8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Select Competitors (Total 43 Featured) -

  • Abbott Laboratories
  • Beckman Coulter, Inc.
  • F. Hoffmann-La Roche AG
  • Mindray Medical International Ltd.
  • Siemens Healthineers
  • Sysmex Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Hematology Diagnostics - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Blood count by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Blood count by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 3: World 16-Year Perspective for Blood count by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Platelet function by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Platelet function by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 6: World 16-Year Perspective for Platelet function by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Hemoglobin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Hemoglobin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 9: World 16-Year Perspective for Hemoglobin by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Hematocrit by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Hematocrit by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 12: World 16-Year Perspective for Hematocrit by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 15: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 18: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 19: World Hematology Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hematology Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hematology Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 22: World 16-Year Perspective for Hematology Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 25: World 16-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 28: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 31: World 16-Year Perspective for Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Hematology Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2014, 2023 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2023 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2014, 2023 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2023 & 2030
  • JAPAN
    • Hematology Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2014, 2023 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2023 & 2030
  • CHINA
    • Hematology Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 61: China 16-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2014, 2023 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 64: China 16-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 67: China 16-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2023 & 2030
  • EUROPE
    • Hematology Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2014, 2023 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Hematology Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Hematology Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Hematology Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2023 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2023 & 2030
  • FRANCE
    • Hematology Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 82: France 16-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2014, 2023 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 85: France 16-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 88: France 16-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2023 & 2030
  • GERMANY
    • Hematology Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2014, 2023 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2023 & 2030
  • ITALY
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2014, 2023 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • Hematology Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 107: UK Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2014, 2023 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 115: UK 16-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2023 & 2030
  • SPAIN
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 118: Spain 16-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2014, 2023 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 121: Spain 16-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 124: Spain 16-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2023 & 2030
  • RUSSIA
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 127: Russia 16-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2014, 2023 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 130: Russia 16-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 133: Russia 16-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 136: Rest of Europe 16-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2014, 2023 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 139: Rest of Europe 16-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 142: Rest of Europe 16-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • Hematology Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 145: Asia-Pacific 16-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2014, 2023 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 148: Asia-Pacific 16-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Hematology Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Hematology Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 151: Asia-Pacific 16-Year Perspective for Hematology Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2023 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 154: Asia-Pacific 16-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2023 & 2030
  • AUSTRALIA
    • Hematology Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 157: Australia 16-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2014, 2023 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 160: Australia 16-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 163: Australia 16-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2023 & 2030
  • INDIA
    • Hematology Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
    • TABLE 164: India Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 166: India 16-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2014, 2023 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 169: India 16-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 172: India 16-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2023 & 2030
  • SOUTH KOREA
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 175: South Korea 16-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2014, 2023 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 178: South Korea 16-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 181: South Korea 16-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2023 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2014, 2023 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 16-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2023 & 2030
  • LATIN AMERICA
    • Hematology Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 193: Latin America 16-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2014, 2023 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 196: Latin America 16-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Hematology Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Hematology Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 199: Latin America 16-Year Perspective for Hematology Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2023 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 202: Latin America 16-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2023 & 2030
  • ARGENTINA
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 205: Argentina 16-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2014, 2023 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 208: Argentina 16-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 211: Argentina 16-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2023 & 2030
  • BRAZIL
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 214: Brazil 16-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2014, 2023 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 217: Brazil 16-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 220: Brazil 16-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2023 & 2030
  • MEXICO
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 223: Mexico 16-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2014, 2023 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 226: Mexico 16-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 229: Mexico 16-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2023 & 2030
  • REST OF LATIN AMERICA
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 232: Rest of Latin America 16-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2014, 2023 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 235: Rest of Latin America 16-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 238: Rest of Latin America 16-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2023 & 2030
  • MIDDLE EAST
    • Hematology Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 241: Middle East 16-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2014, 2023 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 244: Middle East 16-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Hematology Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Hematology Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 247: Middle East 16-Year Perspective for Hematology Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2023 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 250: Middle East 16-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2023 & 2030
  • IRAN
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 253: Iran 16-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2014, 2023 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 256: Iran 16-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 259: Iran 16-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2023 & 2030
  • ISRAEL
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 262: Israel 16-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2014, 2023 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 265: Israel 16-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 268: Israel 16-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2023 & 2030
  • SAUDI ARABIA
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 271: Saudi Arabia 16-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2014, 2023 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 274: Saudi Arabia 16-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 277: Saudi Arabia 16-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2023 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 280: UAE 16-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2014, 2023 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 283: UAE 16-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 286: UAE 16-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2023 & 2030
  • REST OF MIDDLE EAST
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 289: Rest of Middle East 16-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2014, 2023 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 292: Rest of Middle East 16-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 295: Rest of Middle East 16-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2023 & 2030
  • AFRICA
    • Hematology Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Hematology Diagnostics by Test Type - Blood count, Platelet function, Hemoglobin and Hematocrit Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 298: Africa 16-Year Perspective for Hematology Diagnostics by Test Type - Percentage Breakdown of Value Sales for Blood count, Platelet function, Hemoglobin and Hematocrit for the Years 2014, 2023 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Hematology Diagnostics by End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 301: Africa 16-Year Perspective for Hematology Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Hematology Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Hematology Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 304: Africa 16-Year Perspective for Hematology Diagnostics by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2023 & 2030

IV. COMPETITION